Navigation Links
Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret
Date:11/5/2009

WELLINGTON, Colo., Nov. 5 /PRNewswire/ -- The endangered black-footed ferrets inhabit prairie dog towns in the western U.S. This rare carnivore feeds on prairie dogs. The prairie dogs are very susceptible to plague and often entire population die-offs in towns occur. The U.S. Fish & Wildlife Service (FWS) has implemented a ferret breeding program and has been releasing trained, captive ferrets into their formerly native habitat. Unfortunately, plague can sweep through and decimate an entire prairie dog town, eliminate the food supply to ferrets thus starving the small carnivores.

A standard procedure used by the FWS is to proactively dust prairie dog burrows with an insecticide known as Deltamethrin, which kills fleas and protects the prairie dogs from being bitten by plague carrying vector.

This is where two small Colorado-based companies play a role in black footed-ferret protection. Genesis Labs, using grant funds provided by the CDC, has developed prairie dog bait, containing a systemic insecticide. The rodent eats the bait and is not harmed, but the insecticide is absorbed into the blood of the prairie dog. When fleas take a blood meal from the rodent, they are killed within a matter of minutes.

The innovative product is EPA registered and marketed by Scimetrics Ltd. Corp. under the name Kaput Rodent Flea Control Bait. It is the only product of its kind in the world. Genesis and Scimetrics are also working with the Department of Defense and have developed a similar product to control sand flies in the Middle East. U.S. troops serving there are victims of a disease known as cutaneous leishmaniasis. Much like the prairie dogs association with fleas and plague, leishmaniasis is associated with the sand fly and a rodent known as the fat sand rat.

Field testing using Kaput Rodent Flea Control Bait by the FWS initiated in 2009, with more research to be conducted next spring and summer. Preliminary results show that the bait may assist at managing flea populations within prairie dog towns. Genesis and Scimetrics are developing a second product that may be available within two years. That bait would have a longer residual effect in the blood and kill fleas over a longer period. Genesis is committed to working with the FWS in developing innovative products to help protect the endangered black-footed ferret. For more information on Genesis visit their website at www.genesislabs.com.

SOURCE Richland Foundation


'/>"/>
SOURCE Richland Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Colorado Center for Reproductive Medicine Improves Pregnancy and Implantation Rates Using Comprehensive Chromosomal Screening of IVF Embryos
2. Childrens Hospital in Colorado Rounds off List of 24 Cord Blood Transplant Centers Worldwide Enrolling for ExCell Trial Studying StemEx(R) for Leukemia and Lymphoma
3. Colorado Stem Cell Awareness Rally to Take Place in Denver, Colorado on June 13th, 2009
4. Dr. Lawrence Spivack, a LASIK Eye Surgeon Expert Serving Denver, Colorado, Joins Elite Circle of Surgeons Listed at Trusted LASIK Surgeons
5. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
6. Matthew B. Wiener, CEO of Pharmatech, Inc., Is Awarded the Cancer Leadership Award From the Colorado Cancer Coalition
7. NIH Funds $1M Research at Quest Product Development and University of Colorado for New Digitally-Controlled Endoscopes
8. Baxa Corporation Wins Two Colorado BMA 2008 Gold Key Awards
9. Baxa Announces Colorado BioScience Association Sponsorship
10. Kaiser Permanente Colorado Opens Center for Health Dissemination and Implementation Research
11. PDI and Physicians Interactive Partner To Provide Integrated, Personal and Digital Solutions to Life Sciences Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... Blood Corporation (NYSE: CO ) ("CCBC" or ... laboratory testing, hematopoietic stem cell processing and stem cell ... the third quarter and first nine months of fiscal ... Quarter of Fiscal 2017 Highlights Revenues ... 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... 23, 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ... biopharmaceutical company in China, today announced its financial results for ... Fourth Quarter 2016 Financial Highlights ... 21.7% in RMB terms, or increased by 13.6% in USD ... quarter of 2015. Gross profit increased by ...
(Date:2/24/2017)... 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), ... a Key Opinion Leader event to highlight new clinical ... poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium ... will be held in-person and via live webcast on ... AM PST at the Lotte New York Palace Hotel ...
Breaking Biology Technology:
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... , its innovative, highly flexible and award winning eClinical ... customers. iMedNet is a proven Software-as-a-Service (SaaS) ... Data Capture (EDC), but also delivers an entire suite ...
(Date:2/6/2017)... According to Acuity Market Intelligence, ongoing ... to continue to embrace biometric and digital identification ... Border Control (ABC) eGates and 1436 Automated Passport ... 163 ports of entry across the globe. Deployments ... combined CAGR of 37%. APC Kiosks reached 75% ...
(Date:2/2/2017)...   TapImmune, Inc. (NASDAQ: ... the development of innovative peptide and gene-based immunotherapeutics ... metastatic disease, announced today it has successfully completed ... second clinical lot of TPIV 200, the company,s ... manufactured vaccine product will be used to supply ...
Breaking Biology News(10 mins):